Use of Dopaminergic Agents in the Treatment-Resistant Depression

Publisher： Bentham Science Publishers

E-ISSN： 2211-5579|4|2|70-75

ISSN： 2211-5560

Source： Current Psychopharmacology, Vol.4, Iss.2, 2016-02, pp. : 70-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Debate continues over the use of combination antidepressants in patients with treatment-resistant depression

By Alderman Christopher P.  

Drugs & Therapy Perspectives, Vol. 28, Iss. 6, 2012-06 ,pp. : 23-25

Adis International

Access to resources Recommend Favorite

Lamotrigine In Adolescent Treatment–Resistant Depression

By  

Child and Adolescent Psychopharmacology News, Vol. 11, Iss. 2, 2006-05 ,pp. : 1-10

Guilford Publications Inc

Access to resources Recommend Favorite

Quetiapine augmentation in treatment-resistant depression: a naturalistic study

By Šagud Marina   Mihaljević-Peleš Alma   Mück-Šeler Dorotea   Jakovljević Miro   Pivac Nela  

Psychopharmacology, Vol. 187, Iss. 4, 2006-09 ,pp. : 511-514

Springer Publishing Company

Access to resources Recommend Favorite

Ketamine for Treatment-Resistant Unipolar Depression: Current Evidence

By Mathew Sanjay J.   Shah Asim  

CNS Drugs, Vol. 26, Iss. 3, 2012-03 ,pp. : 189-204

Adis International

Access to resources Recommend Favorite

Economic Implications of Treatment-Resistant Depression Among Employees

By Greenberg P.  

PharmacoEconomics, Vol. 22, Iss. 6, 2004-01 ,pp. : 363-373

Adis International

Access to resources Recommend Favorite